{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T06:35:20Z","timestamp":1794983720221,"version":"4.9.1"},"reference-count":133,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1038\/s41590-025-02102-0","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T05:14:11Z","timestamp":1740114851000},"page":"366-377","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["B cell immunometabolism in health and disease"],"prefix":"10.1038","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2667-6530","authenticated-orcid":false,"given":"Eleonora","family":"Martinis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3361-2906","authenticated-orcid":false,"given":"Silvia","family":"Tonon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9693-3985","authenticated-orcid":false,"given":"Alessandra","family":"Colamatteo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"La Cava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9429-0616","authenticated-orcid":false,"given":"Giuseppe","family":"Matarese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo Ennio Michele","family":"Pucillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,21]]},"reference":[{"key":"2102_CR1","doi-asserted-by":"crossref","unstructured":"Chapman, N. M. & Chi, H. Metabolic adaptation of lymphocytes in immunity and disease. Immunity 55, 14\u201330 (2022). This review describes how metabolic factors and reprogramming shape the adaptive immune responses against infection, inflammation and cancer.","DOI":"10.1016\/j.immuni.2021.12.012"},{"key":"2102_CR2","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.immuni.2016.01.028","volume":"44","author":"C Procaccini","year":"2016","unstructured":"Procaccini, C. et al. The proteomic landscape of human ex vivo regulatory and conventional T cells reveals specific metabolic requirements. Immunity 44, 406\u2013421 (2016).","journal-title":"Immunity"},{"key":"2102_CR3","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.immuni.2015.04.005","volume":"42","author":"EC Rosser","year":"2015","unstructured":"Rosser, E. C. & Mauri, C. Regulatory B cells: origin, phenotype, and function. Immunity 42, 607\u2013612 (2015).","journal-title":"Immunity"},{"key":"2102_CR4","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/cdd.2017.52","volume":"24","author":"M Stein","year":"2017","unstructured":"Stein, M. et al. A defined metabolic state in pre B cells governs B-cell development and is counterbalanced by Swiprosin-2\/EFhd1. Cell Death Differ. 24, 1239\u20131252 (2017).","journal-title":"Cell Death Differ."},{"key":"2102_CR5","doi-asserted-by":"publisher","first-page":"154","DOI":"10.4049\/jimmunol.0800167","volume":"184","author":"H Kojima","year":"2009","unstructured":"Kojima, H. et al. Differentiation stage-specific requirement in hypoxia-inducible factor-1\u03b1\u2013regulated glycolytic pathway during murine B cell development in bone marrow. J. Immunol. 184, 154\u2013163 (2009).","journal-title":"J. Immunol."},{"key":"2102_CR6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1146\/annurev.immunol.22.012703.104807","volume":"22","author":"M Busslinger","year":"2004","unstructured":"Busslinger, M. Transcriptional control of early B cell development. Ann. Rev. Immunol. 22, 55\u201379 (2004).","journal-title":"Ann. Rev. Immunol."},{"key":"2102_CR7","doi-asserted-by":"crossref","unstructured":"Schwickert, T. A. et al. Stage-specific control of early B cell development by the transcription factor Ikaros. Nat. Immunol. 15, 283\u2013293 (2014). This work reveals that two transcription factors, PAX5 and IKZF1, impose a state of chronic energy deprivation in B cells by limiting the amount of ATP to insufficient levels for malignant transformation.","DOI":"10.1038\/ni.2828"},{"key":"2102_CR8","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nature21076","volume":"542","author":"LN Chan","year":"2017","unstructured":"Chan, L. N. et al. Metabolic gatekeeper function of B-lymphoid transcription factors. Nature 542, 479\u2013483 (2017).","journal-title":"Nature"},{"key":"2102_CR9","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S1471-4906(03)00119-4","volume":"24","author":"JB Chung","year":"2003","unstructured":"Chung, J. B., Silverman, M. & Monroe, J. G. Transitional B cells: step by step towards immune competence. Trends Immunol. 24, 343\u2013349 (2003).","journal-title":"Trends Immunol."},{"key":"2102_CR10","doi-asserted-by":"crossref","unstructured":"Clarke, A. J., Riffelmacher, T., Braas, D., Cornall, R. J. & Simon, A. K. B1a B cells require autophagy for metabolic homeostasis and self-renewal. J. Exp. Med. 215, 399\u2013413 (2018). This article shows the role of GSK3 in B cells as a metabolic sensor required for several functions, including regulation of B cell size, mitochondrial biogenesis, and glycolysis.","DOI":"10.1084\/jem.20170771"},{"key":"2102_CR11","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/ni.3664","volume":"18","author":"J Jellusova","year":"2017","unstructured":"Jellusova, J. et al. Gsk3 is a metabolic checkpoint regulator in B cells. Nat. Immunol. 18, 303\u2013312 (2017).","journal-title":"Nat. Immunol."},{"key":"2102_CR12","doi-asserted-by":"publisher","first-page":"4458","DOI":"10.1182\/blood-2005-12-4788","volume":"107","author":"CA Doughty","year":"2006","unstructured":"Doughty, C. A. et al. Antigen receptor\u2013mediated changes in glucose metabolism in B lymphocytes: role of phosphatidylinositol 3-kinase signaling in the glycolytic control of growth. Blood 107, 4458\u20134465 (2006).","journal-title":"Blood"},{"key":"2102_CR13","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/s41590-018-0156-5","volume":"19","author":"M Akkaya","year":"2018","unstructured":"Akkaya, M. et al. Second signals rescue B cells from activation-induced mitochondrial dysfunction and death. Nat. Immunol. 19, 871\u2013884 (2018).","journal-title":"Nat. Immunol."},{"key":"2102_CR14","doi-asserted-by":"crossref","unstructured":"Waters, L. R., Ahsan, F. M., Wolf, D. M., Shirihai, O. & Teitell, M. A. Initial B cell activation induces metabolic reprogramming and mitochondrial remodeling. iScience 5, 99\u2013109 (2018). This article reports that, unlike other lymphocytes that typically rely on aerobic glycolysis for rapid proliferation, dividing GC B cells oxidize fatty acids and conduct minimal glycolysis.","DOI":"10.1016\/j.isci.2018.07.005"},{"key":"2102_CR15","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41590-020-0598-4","volume":"21","author":"FJ Weisel","year":"2020","unstructured":"Weisel, F. J. et al. Germinal center B cells selectively oxidize fatty acids for energy while conducting minimal glycolysis. Nat. Immunol. 21, 331\u2013342 (2020).","journal-title":"Nat. Immunol."},{"key":"2102_CR16","doi-asserted-by":"publisher","first-page":"12435","DOI":"10.1073\/pnas.0805460105","volume":"105","author":"KL Otipoby","year":"2008","unstructured":"Otipoby, K. L. et al. BAFF activates Akt and Erk through BAFF-R in an IKK1-dependent manner in primary mouse B cells. Proc. Natl Acad. Sci. USA 105, 12435\u201312438 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2102_CR17","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nri3383","volume":"13","author":"A Cerutti","year":"2013","unstructured":"Cerutti, A., Cols, M. & Puga, I. Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes. Nat. Rev. Immunol. 13, 118\u2013132 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"2102_CR18","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.cmet.2017.12.007","volume":"27","author":"S Jiang","year":"2018","unstructured":"Jiang, S., Yan, W., Wang, S. E. & Baltimore, D. Let-7 suppresses B cell activation through restricting the availability of necessary nutrients. Cell Metab. 27, 393\u2013403 (2018).","journal-title":"Cell Metab."},{"key":"2102_CR19","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1016\/j.celrep.2015.10.072","volume":"13","author":"W-HW Lin","year":"2015","unstructured":"Lin, W.-H. W. et al. Asymmetric PI3K signaling driving developmental and regenerative cell fate bifurcation. Cell Rep. 13, 2203\u20132218 (2015).","journal-title":"Cell Rep."},{"key":"2102_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1025","volume":"12","author":"T Cao","year":"2022","unstructured":"Cao, T. et al. Mitochondrial regulation of acute extrafollicular B-cell responses to COVID-19 severity. Clin. Transl. Med. 12, e1025 (2022).","journal-title":"Clin. Transl. Med."},{"key":"2102_CR21","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nature19334","volume":"537","author":"SH Cho","year":"2016","unstructured":"Cho, S. H. et al. Germinal centre hypoxia and regulation of antibody qualities by a hypoxia response system. Nature 537, 234\u2013238 (2016).","journal-title":"Nature"},{"key":"2102_CR22","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1038\/s41590-023-01540-y","volume":"24","author":"R Sharma","year":"2023","unstructured":"Sharma, R. et al. Distinct metabolic requirements regulate B cell activation and germinal center responses. Nat. Immunol. 24, 1358\u20131369 (2023).","journal-title":"Nat. Immunol."},{"key":"2102_CR23","doi-asserted-by":"publisher","first-page":"110939","DOI":"10.1016\/j.isci.2024.110939","volume":"27","author":"BT Paradoski","year":"2024","unstructured":"Paradoski, B. T. et al. PI3K-dependent reprogramming of hexokinase isoforms controls glucose metabolism and functional responses of B lymphocytes. iScience 27, 110939 (2024).","journal-title":"iScience"},{"key":"2102_CR24","doi-asserted-by":"publisher","first-page":"e153436","DOI":"10.1172\/JCI153436","volume":"132","author":"A D\u2019Avola","year":"2022","unstructured":"D\u2019Avola, A. et al. PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphoma. J. Clin. Invest. 132, e153436 (2022).","journal-title":"J. Clin. Invest."},{"key":"2102_CR25","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.4049\/jimmunol.2400285","volume":"213","author":"M Li","year":"2024","unstructured":"Li, M. et al. CPT2-mediated fatty acid oxidation is dispensable for humoral immunity. J. Immunol. 213, 1139\u20131149 (2024).","journal-title":"J. Immunol."},{"key":"2102_CR26","doi-asserted-by":"publisher","first-page":"10516","DOI":"10.1038\/s41467-024-54937-0","volume":"15","author":"R Nakagawa","year":"2024","unstructured":"Nakagawa, R. et al. Epi-microRNA mediated metabolic reprogramming counteracts hypoxia to preserve affinity maturation. Nat. Commun. 15, 10516 (2024).","journal-title":"Nat. Commun."},{"key":"2102_CR27","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.immuni.2016.06.011","volume":"45","author":"WY Lam","year":"2016","unstructured":"Lam, W. Y. et al. Mitochondrial pyruvate import promotes long-term survival of antibody-secreting plasma cells. Immunity 45, 60\u201373 (2016).","journal-title":"Immunity"},{"key":"2102_CR28","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.celrep.2015.08.063","volume":"13","author":"J Kunisawa","year":"2015","unstructured":"Kunisawa, J. et al. Mode of bioenergetic metabolism during B cell differentiation in the intestine determines the distinct requirement for vitamin B1. Cell Rep. 13, 122\u2013131 (2015).","journal-title":"Cell Rep."},{"key":"2102_CR29","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1016\/j.celrep.2018.07.084","volume":"24","author":"WY Lam","year":"2018","unstructured":"Lam, W. Y. et al. Metabolic and transcriptional modules independently diversify plasma cell lifespan and function. Cell Rep. 24, 2479\u20132492 (2018).","journal-title":"Cell Rep."},{"key":"2102_CR30","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.4049\/jimmunol.1901474","volume":"205","author":"SK Brookens","year":"2020","unstructured":"Brookens, S. K., Cho, S. H., Basso, P. J. & Boothby, M. R. AMPK\u03b11 in B cells dampens primary antibody responses yet promotes mitochondrial homeostasis and persistence of B cell memory. J. Immunol. 205, 3011\u20133022 (2020).","journal-title":"J. Immunol."},{"key":"2102_CR31","doi-asserted-by":"publisher","first-page":"425","DOI":"10.4049\/jimmunol.1601908","volume":"199","author":"M Torigoe","year":"2017","unstructured":"Torigoe, M. et al. Metabolic reprogramming commits differentiation of human CD27+IgD+ B cells to plasmablasts or CD27\u2212IgD\u2212 cells. J. Immunol. 199, 425\u2013434 (2017).","journal-title":"J. Immunol."},{"key":"2102_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/ti.2024.13029","volume":"37","author":"J Noble","year":"2024","unstructured":"Noble, J. et al. Glycolysis changes in alloreactive memory B cells in highly sensitized kidney transplant recipients undergoing desensitization therapy. Transpl. Int. 37, 13029 (2024).","journal-title":"Transpl. Int."},{"key":"2102_CR33","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1136\/annrheumdis-2021-221464","volume":"81","author":"Y Takeshima","year":"2022","unstructured":"Takeshima, Y. et al. Immune cell multiomics analysis reveals contribution of oxidative phosphorylation to B-cell functions and organ damage of lupus. Ann. Rheum. Dis. 81, 845\u2013853 (2022).","journal-title":"Ann. Rheum. Dis."},{"key":"2102_CR34","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1182\/blood-2013-10-532200","volume":"123","author":"R Jitschin","year":"2014","unstructured":"Jitschin, R. et al. Mitochondrial metabolism contributes to oxidative stress and reveals therapeutic targets in chronic lymphocytic leukemia. Blood 123, 2663\u20132672 (2014).","journal-title":"Blood"},{"key":"2102_CR35","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1038\/sj.leu.2403545","volume":"18","author":"JS Carew","year":"2004","unstructured":"Carew, J. S. et al. Increased mitochondrial biogenesis in primary leukemia cells: the role of endogenous nitric oxide and impact on sensitivity to fludarabine. Leukemia 18, 1934\u20131940 (2004).","journal-title":"Leukemia"},{"key":"2102_CR36","doi-asserted-by":"publisher","first-page":"758","DOI":"10.3109\/10428194.2015.1106533","volume":"57","author":"U Rozovski","year":"2016","unstructured":"Rozovski, U., Hazan-Halevy, I., Barzilai, M., Keating, M. J. & Estrov, Z. Metabolism pathways in chronic lymphocytic leukemia. Leuk. Lymphoma 57, 758\u2013765 (2016).","journal-title":"Leuk. Lymphoma"},{"key":"2102_CR37","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1056\/NEJMra1908213","volume":"383","author":"JA Burger","year":"2020","unstructured":"Burger, J. A. Treatment of chronic lymphocytic leukemia. N. Engl. J. Med. 383, 460\u2013473 (2020).","journal-title":"N. Engl. J. Med."},{"key":"2102_CR38","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1038\/s41388-019-1121-y","volume":"39","author":"AF Barak","year":"2020","unstructured":"Barak, A. F. et al. Bone marrow dendritic cells support the survival of chronic lymphocytic leukemia cells in a CD84 dependent manner. Oncogene 39, 1997\u20132008 (2020).","journal-title":"Oncogene"},{"key":"2102_CR39","first-page":"3","volume":"109","author":"E Viry","year":"2024","unstructured":"Viry, E. & Paggetti, J. Power out chronic lymphocytic leukemia: unplugging OXPHOS\/mTOR pathways to overcome venetoclax resistance. Haematologica 109, 3\u20135 (2024).","journal-title":"Haematologica"},{"key":"2102_CR40","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/nri3814","volume":"15","author":"K Basso","year":"2015","unstructured":"Basso, K. & Dalla-Favera, R. Germinal centres and B cell lymphomagenesis. Nat. Rev. Immunol. 15, 172\u2013184 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"2102_CR41","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/imr.12755","volume":"288","author":"C Mlynarczyk","year":"2019","unstructured":"Mlynarczyk, C., Font\u00e1n, L. & Melnick, A. Germinal center-derived lymphomas: the darkest side of humoral immunity. Immunol. Rev. 288, 214\u2013239 (2019).","journal-title":"Immunol. Rev."},{"key":"2102_CR42","doi-asserted-by":"publisher","first-page":"7824","DOI":"10.1073\/pnas.79.24.7824","volume":"79","author":"R Dalla-Favera","year":"1982","unstructured":"Dalla-Favera, R. et al. Human C-Myc ONC gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc. Natl Acad. Sci. USA 79, 7824\u20137827 (1982).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2102_CR43","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1182\/blood-2012-03-415380","volume":"120","author":"GD Victora","year":"2012","unstructured":"Victora, G. D. et al. Identification of human germinal center light and dark zone cells and their relationship to human B-cell lymphomas. Blood 120, 2240\u20132248 (2012).","journal-title":"Blood"},{"key":"2102_CR44","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1038\/ni.2418","volume":"13","author":"DP Calado","year":"2012","unstructured":"Calado, D. P. et al. The cell-cycle regulator c-Myc is essential for the formation and maintenance of germinal centers. Nat. Immunol. 13, 1092\u20131100 (2012).","journal-title":"Nat. Immunol."},{"key":"2102_CR45","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.cmet.2011.12.009","volume":"15","author":"A Le","year":"2012","unstructured":"Le, A. et al. Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. Cell Metab. 15, 110\u2013121 (2012).","journal-title":"Cell Metab."},{"key":"2102_CR46","doi-asserted-by":"publisher","first-page":"7381","DOI":"10.1128\/MCB.00440-07","volume":"27","author":"J Kim","year":"2007","unstructured":"Kim, J., Gao, P., Liu, Y.-C., Semenza, G. L. & Dang, C. V. Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1. Mol. Cell. Biol. 27, 7381\u20137393 (2007).","journal-title":"Mol. Cell. Biol."},{"key":"2102_CR47","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1038\/ng.2469","volume":"44","author":"J Richter","year":"2012","unstructured":"Richter, J. et al. Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing. Nat. Genet. 44, 1316\u20131320 (2012).","journal-title":"Nat. Genet."},{"key":"2102_CR48","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1021\/acs.jproteome.6b00164","volume":"16","author":"P Schwarzfischer","year":"2017","unstructured":"Schwarzfischer, P. et al. Comprehensive metaboproteomics of Burkitt\u2019s and diffuse large b-cell lymphoma cell lines and primary tumor tissues reveals distinct differences in pyruvate content and metabolism. J. Proteome Res. 16, 1105\u20131120 (2017).","journal-title":"J. Proteome Res."},{"key":"2102_CR49","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1182\/blood-2004-07-2947","volume":"105","author":"S Monti","year":"2005","unstructured":"Monti, S. et al. Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood 105, 1851\u20131861 (2005).","journal-title":"Blood"},{"key":"2102_CR50","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ccr.2012.08.014","volume":"22","author":"P Caro","year":"2012","unstructured":"Caro, P. et al. Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma. Cancer Cell 22, 547\u2013560 (2012).","journal-title":"Cancer Cell"},{"key":"2102_CR51","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.cmet.2019.02.002","volume":"29","author":"J Chiche","year":"2019","unstructured":"Chiche, J. et al. GAPDH expression predicts the response to R-CHOP, the tumor metabolic status, and the response of DLBCL patients to metabolic inhibitors. Cell Metab. 29, 1243\u20131257 (2019).","journal-title":"Cell Metab."},{"key":"2102_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14920","volume":"8","author":"X Zhao","year":"2017","unstructured":"Zhao, X. et al. Unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma. Nat. Commun. 8, 14920 (2017).","journal-title":"Nat. Commun."},{"key":"2102_CR53","doi-asserted-by":"publisher","first-page":"34552","DOI":"10.18632\/oncotarget.16602","volume":"8","author":"K Sekihara","year":"2017","unstructured":"Sekihara, K. et al. Targeting mantle cell lymphoma metabolism and survival through simultaneous blockade of mTOR and nuclear transporter exportin-1. Oncotarget 8, 34552 (2017).","journal-title":"Oncotarget"},{"key":"2102_CR54","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau1167","volume":"11","author":"L Zhang","year":"2019","unstructured":"Zhang, L. et al. Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma. Sci. Transl. Med. 11, eaau1167 (2019).","journal-title":"Sci. Transl. Med."},{"key":"2102_CR55","doi-asserted-by":"publisher","first-page":"1155621","DOI":"10.3389\/fonc.2023.1155621","volume":"13","author":"M Matamala Montoya","year":"2023","unstructured":"Matamala Montoya, M., van Slobbe, G. J. J., Chang, J.-C., Zaal, E. A. & Berkers, C. R. Metabolic changes underlying drug resistance in the multiple myeloma tumor microenvironment. Front. Oncol. 13, 1155621 (2023).","journal-title":"Front. Oncol."},{"key":"2102_CR56","doi-asserted-by":"publisher","first-page":"1125874","DOI":"10.3389\/fimmu.2023.1125874","volume":"14","author":"V Kumar","year":"2023","unstructured":"Kumar, V. & Stewart, J. H. Immunometabolic reprogramming, another cancer hallmark. Front. Immunol. 14, 1125874 (2023).","journal-title":"Front. Immunol."},{"key":"2102_CR57","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1089\/ars.2007.1628","volume":"9","author":"P Vaupel","year":"2007","unstructured":"Vaupel, P., H\u00f6ckel, M. & Mayer, A. Detection and characterization of tumor hypoxia using pO2 histography. Antioxid. Redox Signal. 9, 1221\u20131235 (2007).","journal-title":"Antioxid. Redox Signal."},{"key":"2102_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02683-x","volume":"9","author":"X Meng","year":"2018","unstructured":"Meng, X. et al. Hypoxia-inducible factor-1\u03b1 is a critical transcription factor for IL-10-producing B cells in autoimmune disease. Nat. Commun. 9, 251 (2018).","journal-title":"Nat. Commun."},{"key":"2102_CR59","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fimmu.2016.00020","volume":"7","author":"B Molon","year":"2016","unstructured":"Molon, B., Cal\u00ec, B. & Viola, A. T cells and cancer: how metabolism shapes immunity. Front. Immunol. 7, 20 (2016).","journal-title":"Front. Immunol."},{"key":"2102_CR60","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/imm.12998","volume":"156","author":"J Liu","year":"2019","unstructured":"Liu, J. et al. Deceleration of glycometabolism impedes IgG-producing B-cell-mediated tumor elimination by targeting SATB1. Immunology 156, 56\u201368 (2019).","journal-title":"Immunology"},{"key":"2102_CR61","doi-asserted-by":"publisher","first-page":"e2002810","DOI":"10.1371\/journal.pbio.2002810","volume":"15","author":"TQ Tran","year":"2017","unstructured":"Tran, T. Q. et al. Glutamine deficiency induces DNA alkylation damage and sensitizes cancer cells to alkylating agents through inhibition of ALKBH enzymes. PLoS Biol. 15, e2002810 (2017).","journal-title":"PLoS Biol."},{"key":"2102_CR62","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/jcp.1041240216","volume":"124","author":"J Crawford","year":"1985","unstructured":"Crawford, J. & Cohen, H. J. The essential role of l-glutamine in lymphocyte differentiation in vitro. J. Cell. Physiol. 124, 275\u2013282 (1985).","journal-title":"J. Cell. Physiol."},{"key":"2102_CR63","doi-asserted-by":"publisher","first-page":"579","DOI":"10.4049\/jimmunol.1800602","volume":"202","author":"H Chiu","year":"2019","unstructured":"Chiu, H. et al. The mTORC1\/4E-BP\/eIF4E axis promotes antibody class switching in B lymphocytes. J Immunol. 202, 579\u2013590 (2019).","journal-title":"J Immunol."},{"key":"2102_CR64","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/s41590-020-0678-5","volume":"21","author":"R Vijay","year":"2020","unstructured":"Vijay, R. et al. Infection-induced plasmablasts are a nutrient sink that impairs humoral immunity to malaria. Nat. Immunol. 21, 790\u2013801 (2020).","journal-title":"Nat. Immunol."},{"key":"2102_CR65","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s42255-020-0174-0","volume":"2","author":"B Huang","year":"2020","unstructured":"Huang, B., Song, B. & Xu, C. Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities. Nat. Metab. 2, 132\u2013141 (2020).","journal-title":"Nat. Metab."},{"key":"2102_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17179-4","volume":"11","author":"JA Bibby","year":"2020","unstructured":"Bibby, J. A. et al. Cholesterol metabolism drives regulatory B cell IL-10 through provision of geranylgeranyl pyrophosphate. Nat. Commun. 11, 3412 (2020).","journal-title":"Nat. Commun."},{"key":"2102_CR67","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.molmed.2016.12.001","volume":"23","author":"GM Fuhler","year":"2017","unstructured":"Fuhler, G. M., Eppinga, H. & Peppelenbosch, M. P. Fumarates and cancer. Trends Mol. Med. 23, 3\u20135 (2017).","journal-title":"Trends Mol. Med."},{"key":"2102_CR68","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/s41589-022-01052-0","volume":"18","author":"J Cheng","year":"2022","unstructured":"Cheng, J. et al. Fumarate suppresses B-cell activation and function through direct inactivation of LYN. Nat. Chem. Biol. 18, 954\u2013962 (2022).","journal-title":"Nat. Chem. Biol."},{"key":"2102_CR69","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.immuni.2022.04.017","volume":"55","author":"Z Wang","year":"2022","unstructured":"Wang, Z. et al. Leucine-tRNA-synthase-2-expressing B cells contribute to colorectal cancer immunoevasion. Immunity 55, 1067\u20131081 (2022).","journal-title":"Immunity"},{"key":"2102_CR70","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.4049\/jimmunol.1201920","volume":"190","author":"K Wejksza","year":"2013","unstructured":"Wejksza, K. et al. Cancer-produced metabolites of 5-lipoxygenase induce tumor-evoked regulatory B cells via peroxisome proliferator\u2013activated receptor \u03b1. J. Immunol. 190, 2575\u20132584 (2013).","journal-title":"J. Immunol."},{"key":"2102_CR71","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1042\/bj3430281","volume":"343","author":"AP Halestrap","year":"1999","unstructured":"Halestrap, A. P. & Price, N. T. The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation. Biochem. J. 343, 281\u2013299 (1999).","journal-title":"Biochem. J."},{"key":"2102_CR72","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/ijc.26410","volume":"131","author":"AN Mendler","year":"2012","unstructured":"Mendler, A. N. et al. Tumor lactic acidosis suppresses CTL function by inhibition of p38 and JNK\/c-Jun activation. Int. J. Cancer 131, 633\u2013640 (2012).","journal-title":"Int. J. Cancer"},{"key":"2102_CR73","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.tibs.2018.10.011","volume":"44","author":"L Ippolito","year":"2019","unstructured":"Ippolito, L., Morandi, A., Giannoni, E. & Chiarugi, P. Lactate: a metabolic driver in the tumour landscape. Trends Biochem. Sci. 44, 153\u2013166 (2019).","journal-title":"Trends Biochem. Sci."},{"key":"2102_CR74","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.cell.2018.05.009","volume":"174","author":"ZE Walton","year":"2018","unstructured":"Walton, Z. E. et al. Acid suspends the circadian clock in hypoxia through inhibition of mTOR. Cell 174, 72\u201387 (2018).","journal-title":"Cell"},{"key":"2102_CR75","doi-asserted-by":"crossref","unstructured":"Acharya, A., Das, I., Chandhok, D. & Saha, T. Redox regulation in cancer: a double-edged sword with therapeutic potential. Oxid. Med. Cell. Longev. 3, 23\u201334 (2010).","DOI":"10.4161\/oxim.3.1.10095"},{"key":"2102_CR76","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/imm.13499","volume":"166","author":"Y Fu","year":"2022","unstructured":"Fu, Y., Wang, L., Yu, B., Xu, D. & Chu, Y. Immunometabolism shapes B cell fate and functions. Immunology 166, 444\u2013457 (2022).","journal-title":"Immunology"},{"key":"2102_CR77","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s41577-019-0154-3","volume":"19","author":"M M\u00fcschen","year":"2019","unstructured":"M\u00fcschen, M. Metabolic gatekeepers to safeguard against autoimmunity and oncogenic B cell transformation. Nat. Rev. Immunol. 19, 337\u2013348 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"2102_CR78","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1093\/rheumatology\/keac528","volume":"62","author":"E Itotagawa","year":"2023","unstructured":"Itotagawa, E. et al. SLE stratification based on BAFF and IFN-I bioactivity for biologics and implications of BAFF produced by glomeruli in lupus nephritis. Rheumatology 62, 1988\u20131997 (2023).","journal-title":"Rheumatology"},{"key":"2102_CR79","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1084\/jem.190.11.1697","volume":"190","author":"F Mackay","year":"1999","unstructured":"Mackay, F. et al. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J. Exp. Med. 190, 1697\u20131710 (1999).","journal-title":"J. Exp. Med."},{"key":"2102_CR80","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.bcp.2013.11.006","volume":"87","author":"D Liang","year":"2014","unstructured":"Liang, D. et al. BAFF activates Erk1\/2 promoting cell proliferation and survival by Ca2+-CaMKII-dependent inhibition of PP2A in normal and neoplastic B-lymphoid cells. Biochem. Pharmacol. 87, 332\u2013343 (2014).","journal-title":"Biochem. Pharmacol."},{"key":"2102_CR81","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.4049\/jimmunol.2100356","volume":"208","author":"S-C Choi","year":"2022","unstructured":"Choi, S.-C. et al. Pharmacologically inferred glycolysis and glutaminolysis requirement of B cells in lupus-prone mice. J. Immunol. 208, 2098\u20132108 (2022).","journal-title":"J. Immunol."},{"key":"2102_CR82","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.cmet.2023.03.010","volume":"35","author":"Q Zeng","year":"2023","unstructured":"Zeng, Q. et al. Spleen fibroblastic reticular cell-derived acetylcholine promotes lipid metabolism to drive autoreactive B cell responses. Cell Metab. 35, 837\u2013854 (2023).","journal-title":"Cell Metab."},{"key":"2102_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/srep35349","volume":"6","author":"N Mambetsariev","year":"2016","unstructured":"Mambetsariev, N., Lin, W. W., Wallis, A. M., Stunz, L. L. & Bishop, G. A. TRAF3 deficiency promotes metabolic reprogramming in B cells. Sci. Rep. 6, 35349 (2016).","journal-title":"Sci. Rep."},{"key":"2102_CR84","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.immuni.2007.07.012","volume":"27","author":"P Xie","year":"2007","unstructured":"Xie, P., Stunz, L. L., Larison, K. D., Yang, B. & Bishop, G. A. Tumor necrosis factor receptor-associated factor 3 is a critical regulator of B cell homeostasis in secondary lymphoid organs. Immunity 27, 253\u2013267 (2007).","journal-title":"Immunity"},{"key":"2102_CR85","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1182\/blood-2011-01-330530","volume":"118","author":"Y Hao","year":"2011","unstructured":"Hao, Y., O\u2019Neill, P., Naradikian, M. S., Scholz, J. L. & Cancro, M. P. A B-cell subset uniquely responsive to innate stimuli accumulates in aged mice. Blood 118, 1294\u20131304 (2011).","journal-title":"Blood"},{"key":"2102_CR86","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1182\/blood-2011-01-331462","volume":"118","author":"AV Rubtsov","year":"2011","unstructured":"Rubtsov, A. V. et al. Toll-like receptor 7 (TLR7)\u2013driven accumulation of a novel CD11c+ B-cell population is important for the development of autoimmunity. Blood 118, 1305\u20131315 (2011).","journal-title":"Blood"},{"key":"2102_CR87","doi-asserted-by":"publisher","first-page":"1241531","DOI":"10.3389\/fimmu.2023.1241531","volume":"14","author":"I Ramirez De Oleo","year":"2023","unstructured":"Ramirez De Oleo, I. et al. Phenotypic and functional characteristics of murine CD11c+ B cells which is suppressed by metformin. Front. Immunol. 14, 1241531 (2023).","journal-title":"Front. Immunol."},{"key":"2102_CR88","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41584-022-00786-4","volume":"18","author":"HU Scherer","year":"2022","unstructured":"Scherer, H. U., van der Woude, D. & Toes, R. E. M. From risk to chronicity: evolution of autoreactive B cell and antibody responses in rheumatoid arthritis. Nat. Rev. Rheumatol. 18, 371\u2013383 (2022).","journal-title":"Nat. Rev. Rheumatol."},{"key":"2102_CR89","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s00011-020-01332-2","volume":"69","author":"Y Wang","year":"2020","unstructured":"Wang, Y. et al. Inhibition of glycolysis ameliorate arthritis in adjuvant arthritis rats by inhibiting synoviocyte activation through AMPK\/NF-\u043aB pathway. Inflamm. Res. 69, 569\u2013578 (2020).","journal-title":"Inflamm. Res."},{"key":"2102_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110532","volume":"121","author":"J Qi","year":"2023","unstructured":"Qi, J. et al. IL-27 enhances peripheral B cell glycolysis of rheumatoid arthritis patients via activating mTOR signaling. Int. Immunopharmacol. 121, 110532 (2023).","journal-title":"Int. Immunopharmacol."},{"key":"2102_CR91","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.139032","volume":"5","author":"A Floudas","year":"2020","unstructured":"Floudas, A. et al. Pathogenic, glycolytic PD-1+\u2009B cells accumulate in the hypoxic RA joint. JCI Insight 5, e139032 (2020).","journal-title":"JCI Insight"},{"key":"2102_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08711-2","volume":"10","author":"M Luu","year":"2019","unstructured":"Luu, M. et al. The short-chain fatty acid pentanoate suppresses autoimmunity by modulating the metabolic-epigenetic crosstalk in lymphocytes. Nat. Commun. 10, 760 (2019).","journal-title":"Nat. Commun."},{"key":"2102_CR93","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.immuni.2008.11.003","volume":"29","author":"LA Zenewicz","year":"2008","unstructured":"Zenewicz, L. A. et al. Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 29, 947\u2013957 (2008).","journal-title":"Immunity"},{"key":"2102_CR94","doi-asserted-by":"publisher","first-page":"116","DOI":"10.15252\/embj.201695027","volume":"36","author":"M Villa","year":"2017","unstructured":"Villa, M. et al. Aryl hydrocarbon receptor is required for optimal B\u2010cell proliferation. EMBO J. 36, 116\u2013128 (2017).","journal-title":"EMBO J."},{"key":"2102_CR95","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1016\/j.celrep.2019.10.018","volume":"29","author":"CJM Piper","year":"2019","unstructured":"Piper, C. J. M. et al. Aryl hydrocarbon receptor contributes to the transcriptional program of IL-10-producing regulatory B cells. Cell Rep. 29, 1878\u20131892 (2019).","journal-title":"Cell Rep."},{"key":"2102_CR96","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s41392-022-00948-6","volume":"7","author":"X-Y Wang","year":"2022","unstructured":"Wang, X.-Y. et al. c-Myc-driven glycolysis polarizes functional regulatory B cells that trigger pathogenic inflammatory responses. Sig. Transduct. Target Ther. 7, 105 (2022).","journal-title":"Sig. Transduct. Target Ther."},{"key":"2102_CR97","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/s41590-024-01798-w","volume":"25","author":"HF Bradford","year":"2024","unstructured":"Bradford, H. F. et al. Thioredoxin is a metabolic rheostat controlling regulatory B cells. Nat. Immunol. 25, 873\u2013885 (2024).","journal-title":"Nat. Immunol."},{"key":"2102_CR98","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.664249","volume":"12","author":"MR Boothby","year":"2021","unstructured":"Boothby, M. R. et al. Over-generalizing about GC (hypoxia): pitfalls of limiting breadth of experimental systems and analyses in framing informatics conclusions. Front. Immunol. 12, 664249 (2021).","journal-title":"Front. Immunol."},{"key":"2102_CR99","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1084\/jem.20152002","volume":"213","author":"M W\u00f6hner","year":"2016","unstructured":"W\u00f6hner, M. et al. Molecular functions of the transcription factors E2A and E2-2 in controlling germinal center B cell and plasma cell development. J. Exp. Med. 213, 1201\u20131221 (2016).","journal-title":"J. Exp. Med."},{"key":"2102_CR100","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01029-x","volume":"8","author":"W B\u00e9guelin","year":"2017","unstructured":"B\u00e9guelin, W. et al. EZH2 enables germinal centre formation through epigenetic silencing of CDKN1A and an Rb\u2013E2F1 feedback loop. Nat. Commun. 8, 877 (2017).","journal-title":"Nat. Commun."},{"key":"2102_CR101","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/978-1-0716-1311-5_24","volume":"2285","author":"F Carbone","year":"2021","unstructured":"Carbone, F. et al. Metabolomics, lipidomics, and immunometabolism. Methods Mol. Biol. 2285, 319\u2013328 (2021).","journal-title":"Methods Mol. Biol."},{"key":"2102_CR102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coi.2018.09.019","volume":"57","author":"M Akkaya","year":"2019","unstructured":"Akkaya, M. & Pierce, S. K. From zero to sixty and back to zero again: the metabolic life of B cells. Curr. Opin. Immunol. 57, 1\u20137 (2019).","journal-title":"Curr. Opin. Immunol."},{"key":"2102_CR103","doi-asserted-by":"publisher","first-page":"991188","DOI":"10.3389\/fmolb.2022.991188","volume":"9","author":"Y Vivas-Garc\u00eda","year":"2022","unstructured":"Vivas-Garc\u00eda, Y. & Efeyan, A. The metabolic plasticity of B cells. Front. Mol. Biosci. 9, 991188 (2022).","journal-title":"Front. Mol. Biosci."},{"key":"2102_CR104","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.3324\/haematol.2018.203067","volume":"104","author":"J Lu","year":"2019","unstructured":"Lu, J. et al. Energy metabolism is co-determined by genetic variants in chronic lymphocytic leukemia and influences drug sensitivity. Haematologica 104, 1830\u20131840 (2019).","journal-title":"Haematologica"},{"key":"2102_CR105","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4049\/jimmunol.2200756","volume":"212","author":"SK Brookens","year":"2024","unstructured":"Brookens, S. K. et al. Plasma cell differentiation, antibody quality, and initial germinal center B cell population depend on glucose influx rate. J. Immunol. 212, 43\u201356 (2024).","journal-title":"J. Immunol."},{"key":"2102_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113739","volume":"43","author":"TEH Bierling","year":"2024","unstructured":"Bierling, T. E. H. et al. GLUT1-mediated glucose import in B cells is critical for anaplerotic balance and humoral immunity. Cell Rep. 43, 113739 (2024).","journal-title":"Cell Rep."},{"key":"2102_CR107","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1172\/JCI78083","volume":"125","author":"F Melchers","year":"2015","unstructured":"Melchers, F. Checkpoints that control B cell development. J. Clin. Invest. 125, 2203\u20132210 (2015).","journal-title":"J. Clin. Invest."},{"key":"2102_CR108","doi-asserted-by":"publisher","first-page":"48009","DOI":"10.1074\/jbc.M200305200","volume":"277","author":"JB Petro","year":"2002","unstructured":"Petro, J. B. et al. Transitional type 1 and 2 B lymphocyte subsets are differentially responsive to antigen receptor signaling. J. Biol. Chem. 277, 48009\u201348019 (2002).","journal-title":"J. Biol. Chem."},{"key":"2102_CR109","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.immuni.2011.11.017","volume":"36","author":"E Montecino-Rodriguez","year":"2012","unstructured":"Montecino-Rodriguez, E. & Dorshkind, K. B-1 B cell development in the fetus and adult. Immunity 36, 13\u201321 (2012).","journal-title":"Immunity"},{"key":"2102_CR110","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/eji.1830260137","volume":"26","author":"I Krop","year":"1996","unstructured":"Krop, I. et al. Self-renewal of B-1 lymphocytes is dependent on CD19. Eur. J. Immunol. 26, 238\u2013242 (1996).","journal-title":"Eur. J. Immunol."},{"key":"2102_CR111","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1182\/blood-2008-02-078071","volume":"112","author":"TW LeBien","year":"2008","unstructured":"LeBien, T. W. & Tedder, T. F. B lymphocytes: how they develop and function. Blood 112, 1570\u20131580 (2008).","journal-title":"Blood"},{"key":"2102_CR112","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/nri2656","volume":"9","author":"S Pillai","year":"2009","unstructured":"Pillai, S. & Cariappa, A. The follicular versus marginal zone B lymphocyte cell fate decision. Nat. Rev. Immunol. 9, 767\u2013777 (2009).","journal-title":"Nat. Rev. Immunol."},{"key":"2102_CR113","doi-asserted-by":"publisher","first-page":"3626","DOI":"10.4049\/jimmunol.1302062","volume":"192","author":"A Caro-Maldonado","year":"2014","unstructured":"Caro-Maldonado, A. et al. Metabolic reprogramming is required for antibody production that is suppressed in anergic but exaggerated in chronically BAFF-exposed B cells. J. Immunol. 192, 3626\u20133636 (2014).","journal-title":"J. Immunol."},{"key":"2102_CR114","doi-asserted-by":"publisher","unstructured":"Jellusova, J. & Rickert, R. C. A Brake for B Cell Proliferation: Appropriate responses to metabolic stress are crucial to maintain B cell viability and prevent malignant outgrowth. Bioessays https:\/\/doi.org\/10.1002\/bies.20170007 (2017).","DOI":"10.1002\/bies.20170007"},{"key":"2102_CR115","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/imr.12847","volume":"295","author":"X Teng","year":"2020","unstructured":"Teng, X., Brown, J., Choi, S.-C., Li, W. & Morel, L. Metabolic determinants of lupus pathogenesis. Immunol. Rev. 295, 167\u2013186 (2020).","journal-title":"Immunol. Rev."},{"key":"2102_CR116","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107771","volume":"96","author":"X Chen","year":"2021","unstructured":"Chen, X. et al. Metformin prevents BAFF activation of Erk1\/2 from B-cell proliferation and survival by impeding mTOR-PTEN\/Akt signaling pathway. Int. Immunopharmacol. 96, 107771 (2021).","journal-title":"Int. Immunopharmacol."},{"key":"2102_CR117","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1016\/j.vaccine.2017.03.078","volume":"35","author":"A Diaz","year":"2017","unstructured":"Diaz, A. et al. Metformin improves in vivo and in vitro B cell function in individuals with obesity and type-2 diabetes. Vaccine 35, 2694\u20132700 (2017).","journal-title":"Vaccine"},{"key":"2102_CR118","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/s41422-020-0291-z","volume":"30","author":"EM P\u00e5lsson-McDermott","year":"2020","unstructured":"P\u00e5lsson-McDermott, E. M. & O\u2019Neill, L. A. J. Targeting immunometabolism as an anti-inflammatory strategy. Cell Res. 30, 300\u2013314 (2020).","journal-title":"Cell Res."},{"key":"2102_CR119","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/S1474-4422(21)00237-4","volume":"20","author":"DS Reich","year":"2021","unstructured":"Reich, D. S. et al. Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial. Lancet Neurological. 20, 729\u2013738 (2021).","journal-title":"Lancet Neurological."},{"key":"2102_CR120","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00401-022-02411-w","volume":"143","author":"R Li","year":"2022","unstructured":"Li, R. et al. BTK inhibition limits B-cell\u2013T-cell interaction through modulation of B-cell metabolism: implications for multiple sclerosis therapy. Acta Neuropathol. 143, 505\u2013521 (2022).","journal-title":"Acta Neuropathol."},{"key":"2102_CR121","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.4049\/jimmunol.1003319","volume":"187","author":"JL Karnell","year":"2011","unstructured":"Karnell, J. L. et al. Mycophenolic acid differentially impacts B cell function depending on the stage of differentiation. J. Immunol. 187, 3603\u20133612 (2011).","journal-title":"J. Immunol."},{"key":"2102_CR122","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/s41577-019-0257-x","volume":"20","author":"GV Sharonov","year":"2020","unstructured":"Sharonov, G. V., Serebrovskaya, E. O., Yuzhakova, D. V., Britanova, O. V. & Chudakov, D. M. B cells, plasma cells and antibody repertoires in the tumour microenvironment. Nat. Rev. Immunol. 20, 294\u2013307 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"2102_CR123","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-023-00460-1","volume":"11","author":"E Zhang","year":"2023","unstructured":"Zhang, E. et al. Roles and mechanisms of tumour-infiltrating B cells in human cancer: a new force in immunotherapy. Biomark Res. 11, 28 (2023).","journal-title":"Biomark Res."},{"key":"2102_CR124","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","volume":"577","author":"R Cabrita","year":"2020","unstructured":"Cabrita, R. et al. Tertiary lymphoid structures improve immunotherapy and survival in melanoma. Nature 577, 561\u2013565 (2020).","journal-title":"Nature"},{"key":"2102_CR125","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/s41586-019-1922-8","volume":"577","author":"BA Helmink","year":"2020","unstructured":"Helmink, B. A. et al. B cells and tertiary lymphoid structures promote immunotherapy response. Nature 577, 549\u2013555 (2020).","journal-title":"Nature"},{"key":"2102_CR126","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41586-019-1906-8","volume":"577","author":"F Petitprez","year":"2020","unstructured":"Petitprez, F. et al. B cells are associated with survival and immunotherapy response in sarcoma. Nature 577, 556\u2013560 (2020).","journal-title":"Nature"},{"key":"2102_CR127","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s10549-011-1620-1","volume":"132","author":"SMA Mahmoud","year":"2012","unstructured":"Mahmoud, S. M. A. et al. The prognostic significance of B lymphocytes in invasive carcinoma of the breast. Breast Cancer Res. Treat. 132, 545\u2013553 (2012).","journal-title":"Breast Cancer Res. Treat."},{"key":"2102_CR128","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1007\/s12282-021-01227-y","volume":"28","author":"H Kuroda","year":"2021","unstructured":"Kuroda, H. et al. Prognostic value of tumor-infiltrating B lymphocytes and plasma cells in triple-negative breast cancer. Breast Cancer 28, 904\u2013914 (2021).","journal-title":"Breast Cancer"},{"key":"2102_CR129","doi-asserted-by":"publisher","first-page":"5994","DOI":"10.1158\/1078-0432.CCR-12-3497","volume":"19","author":"J-Y Shi","year":"2013","unstructured":"Shi, J.-Y. et al. Margin-infiltrating CD20+ B cells display an atypical memory phenotype and correlate with favorable prognosis in hepatocellular carcinoma. Clin. Cancer Res. 19, 5994\u20136005 (2013).","journal-title":"Clin. Cancer Res."},{"key":"2102_CR130","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1136\/gutjnl-2015-310814","volume":"66","author":"M Garnelo","year":"2017","unstructured":"Garnelo, M. et al. Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma. Gut 66, 342\u2013351 (2017).","journal-title":"Gut"},{"key":"2102_CR131","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.immuni.2022.02.001","volume":"55","author":"M Meylan","year":"2022","unstructured":"Meylan, M. et al. Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer. Immunity 55, 527\u2013541 (2022).","journal-title":"Immunity"},{"key":"2102_CR132","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2021.1900635","volume":"10","author":"J Gunderson","year":"2021","unstructured":"Gunderson, J. et al. Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer. Oncoimmunology 10, 1900635 (2021).","journal-title":"Oncoimmunology"},{"key":"2102_CR133","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-49581-4","volume":"9","author":"Y Murakami","year":"2019","unstructured":"Murakami, Y. et al. Increased regulatory B cells are involved in immune evasion in patients with gastric cancer. Sci. Rep. 9, 13083 (2019).","journal-title":"Sci. Rep."}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02102-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02102-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02102-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T13:10:14Z","timestamp":1741007414000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02102-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,21]]},"references-count":133,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["2102"],"URL":"https:\/\/doi.org\/10.1038\/s41590-025-02102-0","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,21]]},"assertion":[{"value":"30 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}